An attractive therapeutic target, mTOR pathway, in ALK+ anaplastic large cell lymphoma
- PMID: 18418091
- DOI: 10.1097/PAP.0b013e318166139f
An attractive therapeutic target, mTOR pathway, in ALK+ anaplastic large cell lymphoma
Comment on
-
Oncogenic tyrosine kinase NPM/ALK induces activation of the rapamycin-sensitive mTOR signaling pathway.Oncogene. 2007 Aug 16;26(38):5606-14. doi: 10.1038/sj.onc.1210346. Epub 2007 Mar 12. Oncogene. 2007. PMID: 17353907
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous